OSE Immunotherapeutics To Present Corporate Overview At Upcoming BIO CEO & Investor Conference New York February 13-14, 2017
Nantes, February 7, 2017, 6:00 p.m. - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnémo: OSE) announced today that its management team will present an overview of the Company's business and will be available to participate in one-on-one meetings with investors at the BIO CEO & Investor Conference to be held February 13-14, 2017, in New York, NY.
The details of OSE Immunotherapeutics' presentation are as follows:
Event: BIO CEO & Investor Conference
Date: Tuesday, February 14, 2017
Time: 2:00 pm EST
Location: Room Park South, The Waldorf Astoria - 301 Park Avenue, New York, NY
The presentation will be webcast live and remain available for 3 months thereafter on: http://www.veracast.com/webcasts/bio/ceoinvestor2017/59222288295.cfm
The details of OSE Immunotherapeutics' presentation are as follows:
Event: BIO CEO & Investor Conference
Date: Tuesday, February 14, 2017
Time: 2:00 pm EST
Location: Room Park South, The Waldorf Astoria - 301 Park Avenue, New York, NY
The presentation will be webcast live and remain available for 3 months thereafter on: http://www.veracast.com/webcasts/bio/ceoinvestor2017/59222288295.cfm